Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer
Clinical trial NCT03237572 · TERMINATED
Trial details
- NCT number
- NCT03237572
- Sponsor
- Patrick Dillon, MD
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-25
- Primary completion
- 2022-06-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.